Boniva (ibandronate), a new bisphosphonate for osteoporosis

We're getting questions about Boniva (ibandronate), a new bisphosphonate for osteoporosis.

It'll be the first one approved for dosing once a MONTH.

Bisphosphonates are good candidates for intermittent dosing. They can remain active in the bone for several weeks or longer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote